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INTRODUCTION

R
etinitis pigmentosa (RP) is a large class of retinal disease caused by a group of inherited gene mutations that cause photoreceptor cell death [1] . The main manifestations are night blindness, progressive visual field damage, fundus pigmentation, abnormal or wave-free retinal electroretinogram, and central vision loss [2] . Retinal metabolism is active, and photoreceptor cells are at a high oxygen level for a long time, which may result in their own oxidative stress [3] . Bcl-2 and caspase-3 are two important members in regulating cell apoptosis [4] . Activation of Bcl-2-related family members and changes in mitochondrial permeability and membrane potential may occur when cells are stimulated by extracellular apoptosis signals or related factors, such as increases in reactive oxygen species (ROS) and widely changes of oxidative stress injury. All of the alteration lead to cascade activation of the caspase-3 family, which inevitably leads to cell apoptosis [5] . During the occurrence and development of RP, oxidative stress injury always occurs, which induced attentional apoptotic effect in photoreceptor cells. The TREK-TRAAK channel belongs to two-pore potassium ion channels family. This member contains TREK-1, TREK-2, and TRAAK [6] . Activation of TRAAK generates background potassium leakage currents that are participated in regulating excitability of cells and the resting membrane potential [7] [8] [9] [10] .
TRAAK is widely expresses in the central nervous system. Activation of TRAAK by polyunsaturated fatty acids in brain tissue has a protective effect on neuronal death induced by cerebral ischemia [11] . In addition, TRAAK also widely expresses in the mouse retina [12] . Our previous studies have
shown that apoptosis of A-RPE19 and human-RPE (hRPE) cells induced by t-BH can be inhibited by TRAAK agonists by activating of TRAAK in vitro [13] [14] . In this study, the channel agonist riluzole was used to activate this channel in the retina of a RP mouse model (rd1 mouse) to observe the changes in apoptosis in the retina-related cell layer and the expression of apoptosis related factors. MATERIALS AND METHODS Ethical Approval All of the animal experiments conformed to the relevant regulations of the ARVO Center on Animal Feeding, Ophthalmology and Visual Research and ethics committee of the Zhongshan Eye Center (ethics code: 2015-131). Animals The rd1 mice (FVB/rd1) and C57BL/6 mice were purchased respectively from Vital River Laboratory Animal Technology Co. Ltd. (Beijing, China) and Southern Medical University (Guangzhou, China). All animals were kept in the SPF laboratory of Zhongshan Ophthalmic Animal Center and were fed with clean food and water (15℃-25℃ and under a 12h light/12h dark schedule. There were 4 groups in the experiment: a C57BL/6 mouse group (C57, n=8) and 24 rd1 mice were stochastically, equally distributed into 3 groups, including blank group (blank), control group (control), and riluzole group (riluzole, Sigma-Aldrich, USA). From postnatal 7d, the riluzole group was injected intraperitoneally riluzole [with 4 mg/kg, dissolved in 1.4% dimethylsulfoxide (DMSO)] every day, and the control group was intraperitoneally injected with 1.4% DMSO (MP Biomedicals, USA) until 14d [15] [16] .
Mice in the blank and C57 groups received no treatment. Mice were received cervical dislocation to dead at 10, 14, and 18d, respectively, and fresh eyeballs were collected for later use. Frozen Sections Fresh eyeballs were rapidly enucleated and placed in liquid nitrogen to snap frozen. Then the tissue was preserved at -80℃ condition until sectioned with optimal cutting temperature compound (Tissue-Tek; Sakura Finetek, Tokyo, Japan). The tissue sections were sliced vertically with a cryostat at 6 µm, every sections were acquired through or a serrata and optic nerve head.
Immunostaining The immunofluorescence staining assay of sections was described previously [17] . First, the tissue sections were deparaffinized and rehydrated, then, at room temperature, the sections were incubated with 1% BSA (MP Biomedicals, USA) and 0.5% Triton X-100 (MP Biomedicals, USA) for 30 min. After that, primary antibodies against TRAAK (1:100; Alomone labs, Israel) in 1% BSA were incubated at 4℃ overnight. Anti-rabbit IgG secondary antibodies (Alexa Fluor ® 555 Conjugate; 1:1000; CST, USA were added for 1h.
We used fluorescence microscope (Olympus, Japan) to acquire immunostaining images.
H&E Staining for Paraffin Sections
The eyeballs of rd1 and C57BL/6 mice were paraffin embedded. The 5 μm thickness of tissue sections were sliced for stained with hematoxylin and eosin (H&E). Then sections were H&E, and images were acquired using a digital imaging system (Olympus, Japan). The outer nuclear layer (ONL) thickness were analyzed and calculated at 200 μm far away from optic nerve head. 
TUNEL Assays
RESULTS
Localization and Expression of TRAAK on Mouse Retinas
TRAAK is represented by red fluorescence and is widely expressed on the retina in rd1 mice and C57BL/6 mice ( Figure  1A) . The relative fluorescence intensity of the riluzole group was increased versus the control and blank group at the three time points. There existed no significant difference between control and blank group ( Figure 1B) .
Riluzole Reduced the Apoptosis of Photoreceptor Cells
The riluzole group was more elevated compared with control and blank group in the thickness of ONL at the three time points; there existed no significant difference between control and blank group (Figure 2 ). In the ONL of the riluzole group at the 3 time points, fewer TUNEL-positive (TUNEL+) cells was detected. Like previous result, no significant differences in the number of TUNEL+ cells between control and blank groups, and the C57 group had almost no TUNEL+ cells ( Figure 3A-3D) .
Riluzole Activated the Expression of TRAAK and
Inhibited the Development of Apoptosis In riluzole group, the mRNA and protein expression levels of TRAAK were significantly upregulated than those in the blank and control group at three time points. The mRNA and protein expression levels of TRAAK between the control and blank group had no significant differences. Versus with the control and blank groups, the mRNA and protein expression levels of Bcl-2 in the riluzole group at the three time points were significantly increased; while the mRNA and protein expression levels of Bax in this group at the three time points were significantly decreased than control and blank groups. Protein expression levels of cleaved caspase-3 in the riluzole group were decreased than control and blank groups at the three time points (Figure 4A-4D) . DISCUSSION The rd1 mouse model is a successful and representative animal model for RP. There are morphological changes mainly in the retinal ONL layer, with gradual thinning over time that leads to the complete disappearance of the ONL. At approximately 8d, the outer segment starts to die, followed by the death of the inner segment and photoreceptor cells, which peaks around 14d and is nearly complete by 21d [18] . In light of this sequence, this study evaluated the occurrence and development of photoreceptor apoptosis from the perspective of morphology and molecular change mechanisms at the early (10d), peak (14d) and later (18d) stages of mouse apoptosis. Cell shrinkage usually happens at early phase of apoptosis and always accompanies with decreasing in intracellular potassium concentration regulating by TRAAK [19] . Hence, we Int J Ophthalmol, Vol. 12, No. 8, Aug.18, 2019 www.ijo.cn Tel: 8629-82245172 8629-82210956 Email: ijopress@163.com speculate reversing potassium outflow at the early stage of apoptosis may alter the progression of apoptosis. Riluzole is a first-line drug for the treatment of lateral sclerosis of spinal cord and has a certain effect on cerebral ischemia, anxiety and other diseases [20] [21] . The effect of riluzole on TRAAK is rapid, reversible, dose-dependent and, unlike TREK-1 or TREK-2, it is a sustained response [22] . A study reported that riluzole protected nerve cell from apoptosis and improved the recovery of retinal function in rats with ischemic injury [23] . Intraperitoneal injection and topical treatments of riluzole can delay the damage of retinal ganglion cells in the glaucoma model of rats with high intraocular pressure [24] . These protective effects may be partially own to activation of TRAAK. In this study, we used riluzole to activate TRAAK in rd1 mice to explore whether there is the same protective effect against apoptosis and to determine the possible mechanism. The distribution and expression of TRAAK in mice retinas are shown in Figure 1 . It can be seen that TRAAK is expressed in almost all retinal layers of the two kinds of mice, mainly in the ganglion cells, ONL, inner nuclear layer and retinal pigment epithelial, which is basically consistent with previous research [25] . TRAAK is widely involved in the physiological activities of the retina, but its specific mechanism of action on the retina remains unclear. In this study, the average fluorescence intensity of TRAAK in ONL in the riluzole group were higher than that in the control and blank groups at all time points. The thickness of the ONL in the riluzole group was thicker than that in the control and blank groups. In riluzole group, we found the quantity of TUNEL-positive cells in the ONL of the were decreased. These results demonstrated that riluzole downregulated the ONL photoreceptor cells' apoptosis by upregulating the expression of the TRAAK in the retina of rd1 mice. To further explore the possible relationship between the expression of TRAAK and apoptosis, Western blot and RT-PCR assays were performed. In the riluzole group, the protein expression of TRAAK was increased, and the mRNA expression showed the same trend. The increase of this expression was consistent with the change in the previous relative fluorescence intensity of TRAAK. The expression of Bax and cleaved-caspase-3 were decreased in the riluzole groups at the level of transcription and translation, and expression of Bcl-2 was elevated. These changes reversed apoptosis signaling in normal rd1 mice, indicating that increased expression of the TRAAK had a protective effect against apoptosis, demonstrating that this channel was involved in early and late regulation of apoptosis. This study had certain limitations. We have manifested riluzole, as a TRAAK channel agonist can protect and even reverse the photoreceptor apoptosis in vitro and vivo. However, the specific mechanism about TRAAK channel regulating apoptosis needs further research. Besides, due to the experimental conditions and other factors, our experiment did not detect the changes of mouse visual function, such as electroretinogram or electrooculogram. Moreover, relative electrophysiological technique to future studies should be included to evaluate TRAAK effect sufficiently. In conclusion, our results show that the use of riluzole increases the expression of the TRAAK in the retina of rd1 mice, delays the apoptosis of photoreceptor cells in the ONL layer of rd1 mice, and inhibits the development of apoptosis. Therefore, TRAAK has potential research value in the treatment of RP.
Anti-apoptotic effect of TRAAK
